The addition of trastuzumab/pertuzumab to perioperative FLOT significantly improved pCR and nodal negativity rates at the price of higher rates of diarrhea and leukopenia.
No takes yet. Share an insight, caveat, or question.
Hofheinz et al. (2022) studied this question.